Abbott India Share Price

Abbott India Share Price

NSE: ABBOTINDIA
|
Pharmaceuticals
|
S Cap
₹ 27,270.00
+₹1,360.00 (5.25%)
1D
Last updated 18 Sep, 2026, 15:52 IST

Abbott India Share Price Today

As of 21 Sep 2026, Abbott India share price is ₹27,270.00. The stock opened at ₹26,035.00, compared to its previous close of ₹25,910.00. During today's trading session, Abbott India share price moved in the range of ₹26,035.00 to ₹27,490.00, with an average price of ₹26,762.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹25,135.00 and a high of ₹30,670.00. On the performance front, Abbott India share price has increased by 3.39% over the last six months and is down 11.72% on a year-on-year basis.

₹26,035.00
5.25% up today
₹27,490.00
1D LOW
1D HIGH

Abbott India Returns Calculator

Circuit
L
H
₹21,820.00
₹32,720.00
52-week
L
H
₹25,135.00
₹30,670.00

About Abbott India

Abbott India Share Price
ISIN
INE358A01014
Sector Market Cap
₹ 57,955.76 Cr

Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.

Abbott India Financial Highlights

  • Revenue: Abbott India reported revenue of ₹7,217.19 crore in FY26 vs ₹6,684.73 crore in FY25. It showed an increase of 7.97% on a yearly basis.
  • Operating Profit: Abbott India reported an operating profit of ₹2,079.27 crore in FY26 vs ₹1,886.95 crore in FY25. It showed an increase of 10.19% on a year-on-year basis.
  • Net Profit: Abbott India reported a net profit of ₹1,552.02 crore in FY26 vs ₹1,414.44 crore in FY25. It showed an increase of 9.73% on a yearly basis.

Abbott India Quarterly Result Highlights

  • Abbott India reported revenue of ₹1,889.05 crore in Jun 2026, compared with ₹1,785.10 crore in Mar 2026, representing an increase of 5.82% on a quarter-on-quarter (QoQ) basis.
  • Abbott India reported an operating profit of ₹572.21 crore in Jun 2026, compared with ₹531.23 crore in Mar 2026, representing an increase of 7.71% on a quarter-on-quarter (QoQ) basis.
  • Abbott India reported a profit of ₹428.52 crore in Jun 2026, compared with ₹394.93 crore in Mar 2026, reflecting an increase of 8.51% on a QoQ basis.
  • The earnings per share (EPS) of Abbott India stood at ₹730.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
74.99%
FII
0.38%
Other DII
1.34%
Retail and other
15.85%
Mutual funds
7.44%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.16%
Dec 20250.18%
Mar 20260.26%
Jun 20260.38%
Mkt Cap Cr
464.94
P/E
35.89
P/B
12.14
ROE
37.86%
D/E
0.04
ROCE
54.90%
Div. Yield
2.41%
EPS(TTM)
730.36
Turnover
1.08
EV/EBITDA
24.72
Net Margin
22.30%
Op. Margin
31.32%
ROA
33.03%
Quick Ratio
1.91
Curr. Ratio
2.62
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Abbott India outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Abbott India appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,40,398.0036.355.2713.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,664.0085.0214.8415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,82,738.0084.7621.7325.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,15,012.0025.044.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,794.0033.023.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,645.0096.8919.9316.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma99,828.1026.902.639.25%0.1911.76%394.820.23%0.3841.58
Lupin98,069.8017.674.3723.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories97,749.4030.712.5711.07%0.1812.54%377.950.68%0.4138.68
Mankind Pharma95,743.9046.305.8711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Abbott India Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,929.05₹6,409.15₹5,848.91₹5,348.73
Other Income₹288.14₹275.58₹248.27₹154.15
Total Revenue₹7,217.19₹6,684.73₹6,097.18₹5,502.88
Total Expenses₹5,137.92₹4,797.78₹4,479.43₹4,229.06
Profit Before Tax₹2,079.27₹1,886.95₹1,617.75₹1,273.82
Tax₹527.25₹472.51₹416.53₹324.41
Profit After Tax₹1,552.02₹1,414.44₹1,201.22₹949.41
EPS - Basic₹730.36₹665.62₹565.28₹446.80
EPS - Diluted₹730.36₹665.62₹565.28₹446.80

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,079.27₹1,886.95₹1,617.75₹1,273.82
Income before WC changes₹1,929.42₹1,715.60₹1,487.90₹1,211.12
Change in Assets-₹123.76-₹310.61₹18.74₹27.19
Change in Liabilities₹53.27₹53.91₹110.64-₹4.06
Change in WC-₹70.49-₹256.70₹129.38₹23.13
Cash flow from Operations₹1,319.24₹1,011.84₹1,212.81₹893.39
Cash flow from Investing-₹371.38₹182.18-₹416.03-₹147.71
Cash flow from Financing-₹1,066.12-₹925.17-₹744.71-₹638.72
Total Cash Flow-₹118.26₹268.85₹52.07₹106.96
Cash (Start of the year)₹560.59₹291.74₹239.67₹132.71
Cash (End of the year)₹442.33₹560.59₹291.74₹239.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,731.24₹1,153.92₹1,947.65₹1,530.40
Current Assets₹3,770.69₹4,763.39₹3,245.84₹3,025.11
Total Assets₹6,501.93₹5,917.31₹5,193.49₹4,555.51
Current Liabilities₹1,476.57₹1,407.19₹1,342.72₹1,206.02
Net Current Asset₹2,294.12₹3,356.20₹1,903.12₹1,819.09
Non-Current Liabilities₹251.17₹276.97₹151.88₹160.95
Equity Capital₹4,774.19₹4,233.15₹3,698.89₹3,188.54
Total Equity & Liabilities₹6,501.93₹5,917.31₹5,193.49₹4,555.51
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.04
Neutral
ATR (14)
583.93
Neutral
STOCH(9,6)
90.66
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
34.02
Bearish
UO(9)
58.96
Neutral
ROC(12)
4.34
Bullish
WillR(14)
-9.34
Bearish
Period
Simple value
Exponential vaue
5D
26196
26341.66
10D
25902.5
26129.29
20D
26057.25
26210.11
50D
27036.5
26553.97
100D
26745.05
26708.23
Volume trend — traded volume by day
18 Sep0L
17 Sep0L
16 Sep0L
15 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Abbott India Share Price
Abbott India
Pharmaceuticals
Add Stock
Add Another

Abbott India Share Price FAQs

Abbott India share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837